openPR Logo
Press release

Diabetic Macular Edema Market - Key Growth Factors and Forecast 2019

Diabetic Macular Edema Market

Diabetic Macular Edema Market

Macular edema is the condition when the fluid and proteins start collecting on or under the macula of the eye thereby resulting in swelling. Due to such swelling, a person’s central eye vision gets distorted. Macular edema is classified into two types namely cystoids macular edema (CME) and diabetic macular edema (DME).

Obtain Report Details @ http://www.transparencymarketresearch.com/diabetic-macular-edema-market.html

Diabetic macular edema is the major reason for loss of vision in patients suffering from diabetic retinopathy. Diabetes patient are reported to have a 10% risk of developing this condition during their lifetime. On the basis of the cause of disease, DME is classified into two types:

Diffuse macular edema: due to abnormalities in dilated capillaries present in the retina.
Focal macular edema: due to abnormalities in microaneurysms
For diagnosing diabetic macular edema, an ophthalmologist checks the retina for symptoms of the disease including leaking blood vessel, retinal swelling, damaged nerve tissues and pale, fatty deposits on the retina. For further confirmation, comprehensive eye examination such as visual acuity test, dilated exam test and tonometry are performed.

Make an Enquiry @ http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=2248

During the initial stages of DME, no treatment is needed unless the patients efficiently control their blood sugar levels. If the condition becomes severe, the standard treatment for diabetic macular edema is laser photocoagulation. This procedure utilizes laser to reduce edema byapplying a pattern of burnsor bycauterizing leaky blood vessels. For avoiding the side-effects of this treatment, retinal specialists apply injections of anti-vascular endothelial growth factorcorticosteroids along with laser photocoagulation. Currently, there are only two approved drugs available in market for treating DME namely Lucentis and Ozurdex. Other treatment methods are currently under clinical trials.

About Us:-

Transparency Market Research is a market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers.

We are privileged with highly experienced team of Analysts, Researchers and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Contact Us:-

Transparency Market Research

90 State Street, Suite 700, Albany, NY 12207

Tel: +1-518-618-1030

USA - Canada Toll Free: 866-552-3453

Email: sales@transparencymarketresearch.com

Website: http://www.transparencymarketresearch.com/

Visit Blog: http://marketresearchreports2017.blogspot.in

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Diabetic Macular Edema Market - Key Growth Factors and Forecast 2019 here

News-ID: 718554 • Views:

More Releases from Transparency Market Research – Pharmaceutical

Plasma Protease C1-inhibitor Treatment Market Estimated to Flourish by 2025
Plasma Protease C1-inhibitor Treatment Market Estimated to Flourish by 2025
A fresh market intelligence study by Transparency Market Research (TMR) states that the business landscape of the global plasma protease c1-inhibitor treatment market is consolidated with intense competitive rivalry among leading players. TMR detects Shire plc led the global plasma protease C1-inhibitor treatment market in 2016. Key factors that account for its dominance are expanded product portfolio, acquisitions, and widespread market presence. Pharming Group N.V., CSL Limited, and Sanquin are
Narcolepsy Market - Global Industry Trends and Forecast - 2019
Narcolepsy Market - Global Industry Trends and Forecast - 2019
Narcolepsy is a chronic neurological disorder, which is characterized by brain’s inability to control the sleep-wake cycle of an individual. This disorder is not caused due to any mental illness, but is mainly caused due to genetic abnormalities occurring from environmental factors or biologic factors. Narcoleptic individuals exhibita typical characteristic symptom, i.e. excessive daytime sleepiness (EDS), where individuals experience disturbed night sleep and abnormal daytime sleep pattern. Narcolepsy disorder is
Primary Systemic Amyloidosis Market- Get Facts About Business Strategies and Financial Status over Forecast Period 2020.
Primary Systemic Amyloidosis Market- Get Facts About Business Strategies and Fin …
Amyloids are the substance made up of abnormally formed protein in the bone marrow that gets saturated in different tissues or organs of the body. The condition is termed as amyloidosis. There are various types of amyloidosis out of which primary systemic amyloidosis are most common, these are associated with plasma cell dyscrasia and has no historical evidence of disease. Kidney, intestines, liver, heart and nerves are the common organs
Natamycin Market - Global Industry Analysis 2024
Natamycin Market - Global Industry Analysis 2024
Natamycin is also known commonly as pimaricin or natacyn. It is an anti-fungal agent produced during aerobic fermentation by the Streptomyces natalensis, a bacterium found commonly in soil. Natamycin is a polyene macrolide anti-biotic Natamycin is sparingly soluble in water and required in very low concentrations. available as an odorless, white, granular powder as well as crystalline solid. Commercially, Natamycin can be produced through industrial scale fermentation process with the

All 5 Releases


More Releases for Macular

Macular Edema Treatment Market Growth Factors and Emerging Trends Forecast to 20 …
Global Macular Edema Treatment Market Analysis 2022-2028 Report provides strategists, marketers and senior management with the critical information they need to assess the global Macular Edema Treatment Market as it emerges from the Covid-19 shut down. The impact of Coronavirus (COVID-19) on global market has reinforced many trends already shaping the industry pre COVID-19, There is a long-term trend towards the repositioning of players as entertainment providers on multiple platforms. This
Macular Edema and Macular Degeneration Market Size, Analysis, Forecast to 2028 | …
Stratagem Market Insights have included the latest addition of a report titled Macular Edema and Macular Degeneration Market to its expansive repository. The report studies primary and secondary research in order to analyze the data effectively. The market study further also draws attention to crucial industry factors such as global clients, potential customers, and sellers, which instigates positive company growth. In order to gauge the turning point of the businesses,
Macular Pucker Treatment Market – Forecast to 2026
The findings reviewed by GME stated that the Global Macular Pucker Treatment Market would grow at a CAGR value of 6.9 percent from 2021 to 2026. The increasing rate of individuals above the age group of 50 with macular pucker issues drives growth of the macular pucker treatment market. Besides the increasing patient rate, launch of advanced treatment therapies and products have resulted in macular pucker treatment being one of
Macular Edema and Macular Degeneration Market Share, Trends and Analysis, Growth …
Macular edema is a condition in which the retinal layers around the fovea is accumulated by the fluid that leads to the vision impairment and also might lead to the vision loss. Macular edema can be of two types, namely cystoid macular edema and diabetic macular edema. In addition to this, the macular degeneration is a condition in which the loss of vision occurs due to the retinal damage and
Diabetic Macular Edema - Pipeline Review, H1 2017
ReportsWorldwide has announced the addition of a new report title Diabetic Macular Edema - Pipeline Review, H1 2017 to its growing collection of premium market research reports. Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Diabetic Macular Edema - Pipeline Review, H1 2017, provides an overview of the Diabetic Macular Edema (Metabolic Disorders) pipeline landscape. Diabetic macular edema (DME) occurs when blood vessels in the retina of patients with diabetes
Growth Macular Edema Therapeutics Market: 2017 - 2025
Macula is oval yellowish area surrounding the center of retina in the eye. Macular edema is the state when fluid and protein start accumulating under macula resulting swelling in the eye. Due to this swelling, central vision of eye get distorted. Macular edema is classified into two types namely cystoids macular edema (CME) and diabetic macular edema (DME). The retina is the light-sensitive tissue at the back of the eye